CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 195 enrolled
Drug / intervention
Medication reconciliation supplemented with MedSafer and deprescribing brochuresother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05585268
NCT05585268N/ACompleted

Electronic Decision Support for Deprescribing in Patients on Hemodialysis: a Prospective, Controlled, Quality Improvement Study

In Brief

A clinical study evaluating Medication reconciliation supplemented with MedSafer and deprescribing brochures for End Stage Renal Disease and 5 related conditions. Completed, enrolled 195 participants across 1 site.

Detailed Summary

Dialysis patients are prescribed an average of 10-12 medications per day, from up to 4-5 different clinicians and have the heaviest pill burden of all chronic conditions given their degree of comorbidity. One strategy for addressing the problem of "medication overload" is through scalable deprescribing interventions. MedSafer is an electronic deprescribing tool that cross-references patient health data with existing deprescribing guidelines and provides a deprescribing report to clinicians to facilitate deprescribing and reducing the burden of polypharmacy. In this study the investigators will test MedSafer on dialysis patients paired with medication reconciliation on an intervention unit compared to a control unit.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedOct 18, 2022
Enrollment StartOct 3, 2022
Primary CompletionDec 1, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 3.7 years ago

Interventions

Medication reconciliation supplemented with MedSafer and deprescribing brochuresother

This unit will act as an intervention unit for the MedRec where MedSafer deprescribing reports will be handed to the treating team and deprescribing brochures from the Canadian Deprescribing Network will be given to patients.